Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
Status:
Completed
Trial end date:
2017-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether a new opioid molecule, NKTR-181, is
effective for the relief of moderate to severe chronic low back pain as compared to a
placebo.